Zymeworks Inc. 8-K

What Happened
Zymeworks Inc. (ZYME) filed a Form 8-K on March 2, 2026, announcing its financial results for the three months and year ended December 31, 2025. The company issued a press release with those results, which is attached to the Form 8-K as Exhibit 99.1.

Key Details

• Press release announcing results dated March 2, 2026; attached as Exhibit 99.1 to the 8-K.
• Reporting period: three months and year ended December 31, 2025.
• Company states it distributes material information through SEC filings, press releases, conference calls, its website (www.zymeworks.com), investor sites (ir.zymeworks.com and related pages), and social media (X: @ZymeworksInc; LinkedIn).
• Information furnished under Items 2.02 and 7.01 (and Exhibit 99.1) is furnished, not “filed,” and therefore is not subject to Section 18 liability or deemed incorporated by reference except as expressly stated.

Why It Matters
This 8-K signals Zymeworks’ public release of its latest earnings and financial condition for Q4 and FY2025 — essential information for investors tracking revenue, expenses, cash position, and progress on operations. The Reg FD disclosure clarifies where the company posts material updates so investors can access the same information simultaneously. Review the attached press release (Exhibit 99.1) or the company’s investor site for the full financial details and metrics.